#USA #New York #Pomerantz LLP #SelectQuote #DOJ Complaint

Pomerantz Law Firm Probes Allegations Against SelectQuote, Inc.

Pomerantz LLP, a leading law firm in corporate, securities, and antitrust class litigation, has initiated a probe concerning claims on behalf of investors of SelectQuote, Inc. (NYSE: SLQT). The investigation has arisen after recent allegations from the U.S. Department of Justice (DOJ) implicating SelectQuote in serious violations of the False Claims Act.

Background of the Investigation

On May 1, 2025, the DOJ disclosed that it had filed a complaint against various health insurance companies and insurance brokers, among which is SelectQuote. The complaint alleges that from 2016 to 2021, SelectQuote engaged in the unethical practice of paying illegal kickbacks to brokers in exchange for enrollments into Medicare Advantage plans. This revelation has raised substantial concerns regarding SelectQuote's business practices and potential frauds against its investors.

Following the announcement of the DOJ's lawsuit, SelectQuote’s stock plummeted by $0.61 per share, marking a significant drop of 19.24% to close at $2.56, reflecting investors' fears about the company's future and potential legal ramifications.

Role of Pomerantz LLP

The firm, headquartered in New York with additional offices in Chicago, Los Angeles, London, Paris, and Tel Aviv, has a storied history in advocating for victims of securities fraud and corporate misconduct. Founded by Abraham L. Pomerantz, recognized as a pioneer in class actions, the firm aims to hold companies accountable for breaches of fiduciary duty and other wrongdoing. Pomerantz has secured numerous multi-million dollar settlements for companies and investors alike, reinforcing their commitment to fight for justice in cases like the one involving SelectQuote.

Implications for Investors

Investors of SelectQuote who believe that they have been affected by the alleged misconduct are encouraged to connect with the firm for guidance. Danielle Peyton, a representative from Pomerantz LLP, is leading this investigation and can be contacted at [email protected] or at 646-581-9980, ext. 7980. Joining the class action could potentially benefit investors who have suffered losses due to these alleged illegal activities.

Conclusion

As the investigation unfolds, the potential implications for SelectQuote's operations and shareholders remain significant. This case serves as a reminder of the importance of corporate governance and ethical standards in the finance and insurance sectors. With legal scrutiny mounting, SelectQuote may be compelled to reassess its business practices and restore investor confidence in light of this troubling situation. Investors are advised to stay informed about developments in this investigation and consider their options going forward. For more information on Pomerantz LLP and to follow updates on this case, visit their official website at www.pomlaw.com.